I first met one of the patients with intracranial hypotension syndrome at Johns Hopkins Hospital during my neuroradiology research fellowship in 2000. Later on, in 2002, this case was published in AJNR.1
After finishing my research fellowship, in my clinical practice, I realized that intracranial hypotension is not a rare syndrome. There were only 40 papers in the literature in 2000, but there are now thousands of papers available on this topic.
First, as usual, I tried to use CT myelography to detect a CSF leak in the spinal region in intracranial hypotension syndrome. However, in 2005 and 2006, my team and I did 2 radiation studies about breast radiation exposure during the CT exam2,3; there I realized that when spinal scanning with CT myelography, a large amount of radiation is absorbed by the breasts, thyroid, and ovaries. Therefore, I thought we should find a different way, without radiation. Later, I saw a paper about CSF leak detection with gadolinium-enhanced MRI in the intracranial region, and I thought that this was a good idea, so I established my research project entitled “Gadolinium-Enhanced MR Cisternography” to evaluate dural leaks in intracranial hypotension syndrome.4 My paper was published in AJNR in 2008, and one of the Senior Editors, Dr. Dillon, wrote an editorial about my paper in the Journal. In addition, I received a lot of positive feedback about my paper; my colleagues around the world wanted a copy of the PDF.
From 2008 to the present, I have used gadolinium-enhanced MR cisternography to evaluate dural leaks in selected intracranial hypotension cases in young female patients, due to the radiation risks from CT myelography. However, intrathecal injection of gadolinium contrast is currently an off-label use. The other main advantage of MR cisternography is in its ability to detect slow or small leaks in intracranial hypotension syndrome.